The Weekly Roundup: March 24-28

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Do CBD Products Belong in Therapeutic Dermatology?

CBD skin care is booming, but are patients getting real benefits? Learn about CBD legality, safety, and potential dermatologic effects.

Journey Medical Launches Emrosi, a Dual-Release Minocycline for Rosacea

The lowest-dose oral minocycline for rosacea is now available by prescription following FDA approval in November 2024.

Celebrating the "Derm Difference": Mona Gohara, MD, on the Impact of National Dermatologist Day

As a featured clinician in EltaMD’s Derm Day campaign, Mona Gohara, MD, spoke about her connection with the brand and the work being done to unify dermatologists and promote skin health.

ESK-001: A Conversation with Jörn Drappa, MD, PhD, of Alumis on Breakthrough Data and the Future of Psoriasis Treatment

At the 2025 AAD Annual Meeting, Alumis Inc. presented promising phase 2 STRIDE trial results for ESK-001, a TYK2 inhibitor showing sustained psoriasis improvements over 52 weeks.

New Study Reveals Risk Factors for Persistent Urticaria

Researchers have identified elevated eosinophil levels as a potential marker for chronic urticaria in pediatric patients.

DELTA 3 Showcases Long-Term Safety and Efficacy of Delgocitinib for Chronic Hand Eczema

Participants from the parent DELTA 1 and 2 studies maintained their disease control and observed a decrease in pain and itch over 52 weeks of treatment.

Open Sandwich” Moisturization Regimen Does Not Affect Bioactivity of Retinols and Retinoids

Asha Patel Shah, MD, MBA, FAAD, discusses recent research on retinol and retinoid bioactivity when layered with moisturizers highlighted at AAD 2025.

The Mycobiome Connection: How Fungi Influence AD

The study identified 2 fungal profiles in AD patients, with 1 subgroup exhibiting distinct fungal dysbiosis.

Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 3

In part 3 of this Frontline Forum supplement, experts discuss surgical innovations in HS, setting treatment expectations, and more.

New Study Compares Topical Serum and Pulse Light Therapy for Rosacea

Each treatment had benefits and disadvantages for patients who struggle with rosacea-associated erythema.

Nanoneedles Enhance CRISPR Base Editing for RDEB Treatment, Achieving 96.5% Correction Efficiency

Nanoneedles boosted CRISPR base editing efficiency in RDEB fibroblasts, enabling precise COL7A1 correction and improved cell function.

Understanding Neomycin-Induced Contact Allergy

Research suggests that neomycin allergy may be underdiagnosed despite its common use in medical and cosmetic formulations.

Biologics Targeting IL-12, IL-23, and IL-17 Reduce Serious Infections in Older Adults with Psoriatic Disease

A study reveals that biologics targeting IL-12, IL-23, and IL-17 lower the risk of serious infections in older adults with psoriatic disease.

Key Insights From the SPD Pre-AAD Meeting: Advances, Challenges, and the Future of Pediatric Dermatology

Mercedes E. Gonzalez, MD, reflects on the SPD meeting as well as challenges and advances in pediatric dermatology.

Quoin Files US Patent Applications for Rare Disease Treatments

The novel treatments will be for patients with orphan conditions like Netherton Syndrome, Peeling Skin Syndrome, SAM Syndrome, and palmoplantar keratoderma.

Expert Recommendations for Personalized AD Treatment

An expert panel of clinicians provided insights on first-line treatments, maintenance strategies, and flare management for AD.

Journal Digest: March 26

This review of the latest dermatologic studies includes insights into atopic dermatitis, including results from a novel topical CBD application, skin mycobiome comparison, and more.

Unraveling Type 2 Inflammation in Skin Diseases

Targeting type 2 cytokines with monoclonal antibodies has revolutionized treatment for inflammatory skin diseases, reducing symptoms and improving quality of life.

Novel Moisturizing Formulation is Effective for Repairing Skin After Microneedling

When compared to a non-active product, the formula improved texture, reduced erythema, and strengthened the skin barrier.

An Up-to-Date Review of Rosacea in Childhood and Adolescence

Researchers behind a recent review shared expert insights, treatment guidelines, and differential diagnosis techniques for pediatric rosacea.

Active Education Outperforms Passive Approaches in Melanoma Detection by Non-Medical Individuals

A study shows active educational interventions improve melanoma detection rates and rule application, with lasting effects over time.

CBD and CBG Ointment Improved Skin in Patients with Atopic Dermatitis

Use of the product showed positive changes in the skin’s hydration, lipid content, transepidermal water loss, and erythema.

Interview Intersection: Expert Interviews From March 2025

Dermatology Times is recapping our exclusive expert interviews from the month of March.

Understanding the Psychological Impact of Melanoma

Nearly half of patients with melanoma experience significant distress, affecting treatment adherence and quality of life.

Patient and Physician Perspectives Assess Long-Term Impact of Tildrakizumab for Psoriasis

Treatment with tildrakizumab was still safe and effective after 1 year with notable improvements in patients’ quality of life.

Novel Synthesized Silver Nanoparticle Shampoo is Comparable to 2% Ketoconazole for SD Treatment

In a prospective study, patients with scalp seborrheic dermatitis saw positive results in efficacy, safety, and quality of life when using the AgNP product.

Can BSZY Cream Reduce Symptoms of Facial Atopic Dermatitis?

The cream contains barrier-repairing ingredients that may enhance self-healing and hydration in affected skin.

Topical Xyngari Meets All Primary Endpoints in Phase 3 Study for Moderate to Severe Acne

Xyngari showed promise as the first once-weekly topical acne treatment, achieving strong phase 3 results with significant efficacy and safety.

Dermatology Times March 2025 Recap

Dermatology Times is looking back on the top stories in dermatology from the month of March.

Fixed-Dose Acne Treatment Gel is Safe and Effective for Hispanic Patients, According to Post-Hoc Analysis

The therapy, which combines clindamycin phosphate, adapalene, and benzoyl peroxide, was effective for Hispanic patients with moderate to severe lesions.

Machine Learning Enhances Laser Treatment Planning

With an increasing demand for laser procedures, AI-based skin assessments may help ensure safer and more effective treatments.

Undersleeping is a Potential Risk Factor for Cutaneous Melanoma

Two-sample Mendelian randomization analysis explored lifestyle factors such as sleep, smoking, alcohol consumption, and sedentary behavior.

Top 5 Articles of the Month: March

Explore the top headlines of the week including insights on recalls, expert pearls, and more.

Review and Meta-Analysis Compares Delgocitinib to Vehicle for Chronic Hand Eczema Treatment

Patients with CHE saw higher treatment success and a favorable safety profile with delgocitinib 20-30 mg/g.

Dermatology Times March 2025 Print Recap

Learn more about the in-depth topics covered in the March 2025 print issue of Dermatology Times.